Gil J. van Lunsen, Director at ARRAY BIOPHARMA INC (ARRY), sold 43,000 shares at $19.08 ($820K) on 2018-06-20, disclosed to the SEC on 2018-06-21.
Open-market sale of $820k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.08 | 21,500 | $410K | 50.0% |
| 2 | $19.08 | 21,500 | $410K | 50.0% |
| Total | $19.08 avg | 43,000 | $820K | 100% |
| Filing → |
| ARRY | SELL | 2018-07-19 | $356K | — | Filing → |
| ARRY | SELL | 2018-05-17 | $330K | — | Filing → |
| ARRY | SELL | 2018-04-18 | $327K | — | Filing → |